National Clinical Practice Guidelines for the management of non-small cell lung cancer in early, locally advanced and metastatic stages

被引：21

作者：

Barron-Barron, Feliciano ^{[1
]}

Guzman-De Aba, Enrique ^{[2
]}

Alatorre-Alexander, Jorge ^{[2
]}

Aldaco-Sarvide, Fernando ^{[3
]}

Bautista-Aragon, Yolanda ^{[4
]}

Blake-Cerda, Monica ^{[5
]}

Carolina Blanco-Vazquez, Yazmin ^{[5
]}

Campos-Gomes, Saul ^{[6
]}

Francisco Corona-Cruz, Jose ^{[1
]}

Antonio Iniguez-Garcia, Marco ^{[2
]}

Javier Lozano-Ruiz, Francisco ^{[7
]}

Maldonado-Magos, Federico ^{[1
]}

de la Mata-Moya, Dolores ^{[5
]}

Manuel Martinez-Barrera, Luis ^{[2
]}

Ramos-Prudencio, Rubi ^{[8
]}

Rodriguez-Cid, Jeronimo ^{[2
]}

Rivera-Rivera, Samuel ^{[4
]}

Rogelio Treth-Rosales, Raul ^{[4
]}

Rodrigo Aguilar-Ortiz, Marco ^{[6
,9
]}

Astudillo-de la Vega, Horacio ^{[4
]}

Javier Barajas-Figueroa, Luis ^{[10
]}

Barroso-Quiroga, Nimbe ^{[11
]}

Blanco-Salazar, Andres ^{[6
]}

Castillo-Ortega, Graciano ^{[12
]}

Manuel Dominguez-Parra, Luis ^{[13
]}

Isabel Enriquez-Aceves, Maria ^{[12
]}

Femandez-Orozco, Armando ^{[4
]}

Antonio Figueroa-Morales, Marco ^{[14
]}

Green-Schneewiss, Leon ^{[5
]}

Alejandro Gonzalez-Garay, Jorge ^{[9
]}

Gonzalez Ramirez-Benfield, Rogelio ^{[15
]}

Guadarrama-Orozco, Alberto ^{[4
]}

Guerrero-Ixtlahuac, Jorge ^{[1
]}

Hernandez-Barajas, David ^{[16
]}

Hernandez-Montes de Oca, Raymundo ^{[5
]}

Kelly-Garcia, Javier ^{[17
]}

Lazaro-Leon, Miguel ^{[18
]}

Silva-Bravo, Fernando ^{[19
]}

Luis Tellez-Becerra, Jose ^{[2
]}

Omar Macedo-Perez, Eleazar ^{[1
]}

Maza-Ramos, Gbert ^{[6
,9
]}

Luis Mayorga-Butron, Jose ^{[20
,21
]}

Beatriz Montano-Velazquez, Bertha ^{[20
]}

Murillo-Medina, Kartha ^{[22
]}

Narvaez-Fernandez, Salvador ^{[12
]}

Javier Ochoa-Carrillo, Francisco ^{[1
]}

Olivares-Beltran, Guillermo ^{[5
]}

Olivares-Torres, Carlos ^{[16
]}

Ponce de Leon-Castillo, Mario ^{[17
]}

Alberto Ponce-Viveros, Mario ^{[4
]}

机构：

[1] Inst Nacl Cancerol, Ciudad De Mexico, Mexico

[2] Inst Nacl Enfermedades Resp, Ciudad De Mexico, Mexico

[3] Inst Seguridad & Serv Sociales Bs Trabajadores Es, Ctr Med Nacl 20 Noviembre, Ciudad De Mexico, Mexico

[4] Inst Mexicano Seguro Social, Ctr Med Nacl Siglo 21, Hosp Oncol, Ciudad De Mexico, Mexico

[5] Ctr Med ABC, Ctr Canc ABC, Ciudad De Mexico, Mexico

[6] Inst Seguridad Social Estado Mexico & Municipios, Ctr Oncol Estatal, Toluca De Lerdo, Estado De Mexic, Mexico

[7] Ctr Oncol Med Sur, Ciudad De Mexico, Mexico

[8] SSA, Inst Nacl Ciencias Med & Nutr Dr Salvador Zubiran, Ciudad De Mexico, Mexico

[9] Guidelines Int Network North Amer, Steering Comitee, New York, NY USA

[10] Grp Angeles, Ciudad De Mexico, Mexico

[11] Hosp Univ Dr Angel Leano, Zapopan, Jalisco, Mexico

[12] Inst Mexicano Seguro Social, Guanajuato, Mexico

[13] Star Med, Tijuana, Baja California, Mexico

[14] Inst Mexicano Seguro Social, Ctr Med Noreste, UMA 25, Nuevo Leon, Mexico

[15] Hosp Civil Guadalajara, Guadalajara, Jalisco, Mexico

[16] Hosp Gen Estado, Hermosillo, Sonora, Mexico

[17] Inst Jaliciense Cancerol, Guadalajara, Jalisco, Mexico

[18] Hosp Gen Mexico Dr Eduardo Liceaga, Ciudad De Mexico, Mexico

[19] Inst Mexicano Seguro Social, Puebla, Mexico

[20] UNAM, Programa Maestria & Doctorado Ciencias Med, Fac Med, Unidad Posgrad, Ciudad De Mexico, Mexico

[21] Inst Nacl Pediat, Ciudad De Mexico, Mexico

[22] Inst Seguridad & Serv Sociales Trabajadores Estad, Hosp Reg Gen Zaragoza, Ciudad De Mexico, Mexico

来源：

SALUD PUBLICA DE MEXICO | 2019年 / 61卷 / 03期

关键词：

lung cancer; non-small cell lung cancer; early stage lung cancer; locally advanced lung cancer; metastatic lung cancer; practice guidelines; evidence based medicine; PHASE-III TRIAL; WHOLE-BRAIN RADIOTHERAPY; PLATINUM-BASED CHEMOTHERAPY; THERAPY ONCOLOGY GROUP; STEREOTACTIC ABLATIVE RADIOTHERAPY; PROPHYLACTIC CRANIAL IRRADIATION; ASSISTED THORACOSCOPIC SURGERY; PARTITIONING ANALYSIS RPA; INDIVIDUAL PATIENT DATA; GROWTH-FACTOR RECEPTOR;

D O I：

10.21149/9916

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Lung cancer is one the leading causes of mortality worldwide. Symptomatic manifestations of the disease generally occur in the advanced-stage setting, and therefore an important number of patients have advanced or metastatic disease by the time they are diagnosed. This situation contributes to a poor prognosis in the treatment of lung cancer. Evidence-based clinical recommendations are of great value to support decision-making for daily practice, and thus improving health care quality and patient outcomes. Objectives. This Clinical Practice Guideline (CPG) contains systematically-developed recommendations to support clinicians, patients and patientcarers, policy makers and other stakeholders in the diagnosis and management of patients with early, advanced and metastatic stages of non-small cell lung cancer. Materials and methods. This document was an initiative of the Mexican Society of Oncology (SMEO) in collaboration with Mexican Center of Clinical Excellence (Cenetec) according to International Standards. Such standards included those described by the IOM, NICE, SIGN and GI-N. An interdisciplinary Guideline Development Group (GDG) was put together which included medical oncologists, surgical oncologistsc, radiation therapists, and methodologists with expertise in critical appraisal, systematic reviews and clinical practice guidelines development. Results. 62 clinical questions were agreed among members of the GDG. With the evidence identified from systematic reviews, the GDG developed clinical recommendations using a Modified Delphi Panel technique. Patients' representatives validated them. Conclusions. These Clinical Practice Guideline aims to support the shared decision-making process for patients with different stages of non-small cell lung cancer. Our goal is to improve health-care quality on these patients.

引用

页码：359 / 414

页数：56

共 50 条

[41] Non-Small Cell Lung Cancer, Version 5.2017 Clinical Practice Guidelines in Oncology
Ettinger, David S.
Wood, Douglas E.
Aisner, Dara L.
Akerley, Wallace
Bauman, Jessica
Chirieac, Lucian R.
D'Amico, Thomas A.
DeCamp, Malcolm M.
Dilling, Thomas J.
Dobelbower, Michael
Doebele, Robert C.
Govindan, Ramaswamy
Gubens, Matthew A.
Hennon, Mark
Horn, Leora
Komaki, Ritsuko
Lackner, Rudy P.
Lanuti, Michael
Leal, Ticiana A.
Leisch, Leah J.
Lilenbaum, Rogerio
Lin, Jules
Loo, Billy W., Jr.
Martins, Renato
Otterson, Gregory A.
Reckamp, Karen
Riely, Gregory J.
Schild, Steven E.
Shapiro, Theresa A.
Stevenson, James
Swanson, Scott J.
Tauer, Kurt
Yang, Stephen C.
Gregory, Kristina
Hughes, Miranda
[J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (04): : 504 - 535
[42] Preface - Lung cancer, part I: radiotherapy and chemotherapy in locally advanced and metastatic non-small cell lung cancer
Jeremic, B
[J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2004, 18 (01) : XVII - XVIII
[43] Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Planchard, D.
Popat, S.
Kerr, K.
Novello, S.
Smit, E. F.
Faivre-Finn, C.
Mok, T. S.
Reck, M.
Van Schil, P. E.
Hellmann, M. D.
Peters, S.
[J]. ANNALS OF ONCOLOGY, 2018, 29 : 192 - 237
[44] Surgical Approach to Locally Advanced Non-Small Cell Lung Cancer
Donington, Jessica S.
Pass, Harvey I.
[J]. CANCER JOURNAL, 2013, 19 (03): : 217 - 221
[45] Trimodality therapy for locally advanced non-small cell lung cancer
Lackner, R. P.
Ganti, A.
Zhen, W.
Copur, M. S.
Vaziri, I. A.
Bolton, M.
Hlavaty, T.
Trujillo, K. P.
Kessinger, M. A.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[46] Drugs and radiopotentiation in locally advanced non-small cell lung cancer
Quoix, E
Moreau, L
Oster, JP
[J]. TREATMENT OPTIMIZATION FOR LUNG CANCER: FROM CLASSICAL TO INNOVATIVE PROCEDURES, 1998, : 207 - 218
[47] Treatment Outcome of Locally Advanced Non-small Cell Lung Cancer
Lee, Heui Kwan
Kwon, Hyoung-Cheol
Lee, Sun Young
Kim, Jung Soo
[J]. RADIATION ONCOLOGY JOURNAL, 2006, 24 (04): : 237 - 242
[48] Proton therapy for locally advanced non-small cell lung cancer
Gjyshi, Olsi
Liao, Zhongxing
[J]. BRITISH JOURNAL OF RADIOLOGY, 2020, 93 (1107):
[49] Multimodality treatment in locally advanced non-small cell lung cancer
Trodella, L
D'Angelillo, RM
Ramella, S
Granone, P
[J]. ANNALS OF ONCOLOGY, 2006, 17 : 32 - 33
[50] Role of immunotherapy in locally advanced non-small cell lung cancer
Levy, A.
Doyen, J.
Botticella, A.
Bourdais, R.
Achkar, S.
Giraud, P.
Du, C.
Naltet, C.
Lavaud, P.
Besse, B.
Pradere, P.
Mercier, O.
Caramella, C.
Planchard, D.
Deutsch, E.
Le Pechoux, C.
[J]. CANCER RADIOTHERAPIE, 2020, 24 (01): : 67 - 72

← 1 2 3 4 5 →